NFKB1 and breast carcinoma: Previous research has shown that WDL can inhibit breast cancer cell growth and promote bone marrow mesenchymal stem cell proliferation by inhibiting nuclear factor-kappa B (NF-κB)a transcription factorand/or androgen receptor (Deng et al., 2019; Nehybová et al., 2017).